Also trades as: DEMANT.CO (CPH) · $vol 15M · WILLF (OTC) · $vol 0M

$23.57

-0.17 (-0.74%)

Weekly Expected Move ±4.5%

$21 $23 $24 $25 $26

OTC · Healthcare · Medical - Devices · Tech Score Buy · Power 69 · $9.9B mcap · 84M float · 0.0003% daily turnover · Short 100% of daily vol

Revenue

$23.0B +2.5% ▲

5Y CAGR: +9.7%

Gross Profit

$17.4B +1.6% ▲

5Y CAGR: +11.3%

Operating Income

$3.9B -11.3% ▼

5Y CAGR: +20.6%

Net Income

$1.5B -35.3% ▼

5Y CAGR: +6.6%

EPS (Diluted)

$3.52 -35.5% ▼

5Y CAGR: +8.5%

EBITDA

$5.4B -7.5% ▼

5Y CAGR: +17.4%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.9B	$19.7B	$22.4B	$22.4B	$23.0B
YoY Growth	+23.7%	+10.1%	+13.9%	-0.1%	+2.5%
Cost of Revenue	$4.6B	$5.0B	$5.9B	$5.3B	$5.6B
Gross Profit	$13.5B	$14.7B	$16.5B	$17.1B	$17.4B
Gross Margin	75.2%	74.4%	73.7%	76.2%	75.6%
R&D Expenses	$1.4B	$1.3B	$1.4B	$1.4B	$1.4B
SG&A Expenses	$9.2B	$10.3B	$11.0B	$11.4B	$12.0B
Operating Expenses	$9.8B	$11.5B	$12.4B	$12.7B	$11.6B
Operating Income	$3.7B	$3.2B	$4.1B	$4.4B	$3.9B
Operating Margin	20.5%	16.3%	18.5%	19.6%	17.0%
Interest Expense	$109M	$191M	$531M	$652M	$532M
Income Before Tax	$3.5B	$2.9B	$3.4B	$3.7B	$3.0B
Tax Expense	$750M	$651M	$839M	$824M	$734M
Net Income	$2.5B	$2.1B	$1.8B	$2.4B	$1.5B
Net Margin	14.0%	10.6%	8.0%	10.6%	6.7%
EPS (Diluted)	$5.35	$4.61	$4.02	$5.45	$3.52
EBITDA	$4.4B	$4.3B	$5.1B	$5.8B	$5.4B
Shares Outstanding	470M	452M	446M	438M	423M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$10.1B	$11.2B	$11.3B	$11.1B	$11.3B	$11.3B	$11.7B	$13.2B
Cost of Revenue	$2.6B	$3.0B	$2.9B	$2.6B	$2.8B	$2.7B	$2.9B	$3.0B
Gross Profit	$7.5B	$8.2B	$8.4B	$8.5B	$8.6B	$8.5B	$8.9B	$10.2B
Gross Margin	74.1%	73.4%	74.3%	76.8%	75.7%	76.0%	75.5%	77.2%
R&D Expenses	$663M	$706M	$704M	$733M	$661M	$730M	$667M	$758M
SG&A Expenses	$5.4B	$5.3B	$5.4B	$5.7B	$5.7B	$6.0B	$6.1B	$7.2B
Operating Expenses	$6.1B	$6.0B	$6.4B	$6.3B	$6.4B	$6.7B	$6.7B	$8.0B
Operating Income	$1.4B	$2.2B	$2.1B	$2.2B	$2.2B	$1.8B	$2.1B	$2.3B
Operating Margin	14.0%	19.4%	18.1%	19.8%	19.5%	16.4%	17.6%	17.1%
Interest Expense	$232M	$406M	$449M	$926M	-$274M	$385M	$395M	$433M
Income Before Tax	$1.4B	$1.6B	$1.7B	$1.8B	$1.9B	$1.5B	$1.5B	$1.6B
Tax Expense	$315M	$397M	$442M	$428M	$396M	$334M	$397M	$362M
Net Income	$1.0B	$581M	$1.2B	$1.2B	$1.2B	$1.1B	$425M	$1.2B
Net Margin	10.2%	5.2%	10.7%	10.8%	10.5%	9.9%	3.6%	9.1%
EPS (Diluted)	$2.31	$1.30	$2.72	$3.09	$2.36	$2.67	$0.85	$2.88
EBITDA	$1.7B	$1.2B	$2.6B	$2.4B	$3.4B	$2.2B	$3.2B	$3.2B
Shares Outstanding	448M	446M	446M	438M	438M	423M	421M	418M

WILYY OTC